Alice Jenh Hsu, Pharm.D., BCPS AQ-ID

Alice Jenh Hsu, PharmD, BCPS AQ-ID

Co-Director, Pediatric Antimicrobial Stewardship Program

Education and Training
Professional Memberships
Clinical and Research Interests
Selected Publications
Contact Information

Education and Training

Pharm.D., Rutgers, The State University of New Jersey Ernest Mario School of Pharmacy Piscataway, NJ (2007)
Pharmacy Practice Resident, The Johns Hopkins Hospital, Baltimore, MD (2008)
Infectious Diseases Specialty Resident, The Johns Hopkins Hospital, Baltimore, MD (2009)

Professional Memberships

Society of Infectious Disease Pharmacists
American Society of Health-System Pharmacists
Maryland Society of Health-System Pharmacy

Clinical and Research Interests

Dr. Hsu’s research interests include investigating the use of antimicrobials in the pediatric population, pharmacokinetics/pharmacodynamics of antimicrobials, and pediatric/adolescent HIV.

Selected Publications

  1. Hsu AJ, Hamdy RF, Huang Y, Olson JA, Ghobrial S, Gerber JS, Hersh AL, Tamma PD. Association Between Vancomycin Trough Concentrations and Duration of Methicillin-Resistant Staphylococcus aureus Bacteremia in Children. J Pediatric Infect Dis Soc. 2017 Sep 14. doi: 10.1093/jpids/pix068. [Epub ahead of print]
  2. Hamdy RF, Hsu AJ, Stockmann C, Olson JA, Bryan M, Hersh AL, Tamma PD, Gerber JS. Epidemiology of Methicillin-Resistant Staphylococcus aureus Bacteremia in Children. Pediatrics. 2017 Jun;139(6). pii: e20170183.
  3. Buckel WR, Ghobrial S, Tamma PD, Milstone AM, Zhao Y, Hsu AJ. Risk Factors for Non-Therapeutic Initial Steady-State Vancomycin Trough Concentrations in Children and Adolescents Receiving High Empiric Doses of Intravenous Vancomycin. Paediatr Drugs. 2017 Feb;19(1):43-51.
  4. Hsu AJ, Neptune A, Adams C, Hutton N, and Agwu AL. Antiretroviral stewardship in a pediatric HIV clinic: development, implementation, and improved Clinical Outcomes. Pediatr Infect Dis J. 2016; 35(6):642-8.
  5. Tamma SM, Hsu AJ, Tamma PD. Prescribing ceftolozane/tazobactam for pediatric patients: current status and future implications. Paediatr Drugs. 2016; 18(1):1-1.
  6. Smith TT, Hsu AJ, Hutton N, Womble F, and Agwu AL. Long-term virologic suppression despite presence of resistance associated mutations among perinatally HIV-infected youth. Pediatr Infect Dis J. 2015; 34:1365–1368.
  7. Hsu AJ, Carroll KC, Milstone AM, Avdic E, Cosgrove SE, Vilasoa M, Tamma PD. The use of a combination antibiogram to assist with the selection of appropriate antimicrobial therapy for carbapenem-resistant Enterobacteriaceae infections. Infect Control Hosp Epidemiol. 2015; 36(12):1458-60.
  8. Hsu AJ, Dabb A, and Arav-Boger R. Auto-induction of voriconazole metabolism in a child with invasive pulmonary aspergillosis. Pharmacotherapy. 2015; 35(4):e20-6.
  9. Tamma PD and Hsu AJ. Optimizing therapy for vancomycin-resistant enterococcus bacteremia in children. Curr Opin Infect Dis. 2014; 27(6):517-27.
  10. Hsu AJ and Tamma PD. The treatment of multi-drug resistant Gram-negative infections in children. Clin Infect Dis. 2014; 58(10):1439-48.
  11. Wong FL, Hsu AJ, Pham PA, Siberry GK, Hutton N, and Agwu AL. Antiretroviral treatment strategies in highly treatment experienced perinatally HIV-infected youth. Pediatr Infect Dis J. 2012; 31: 1279–1283.
  12. Nachega JB, Hsu AJ, Uthman O, Spinewine A, and Pham PA. Antiretroviral therapy adherence and drug-drug interactions in the aging HIV population. AIDS. 2012; 26 Suppl 1:S39-53.

Contact Information

600 North Wolfe Street, Carnegie 180
Baltimore, MD 21287

Email: [email protected]